John Logeman
About John Logeman
John Logeman serves as the US Director of Market Development at Nevro, where he has been instrumental in driving sales growth and team development since 2021. Previously, he held various leadership roles in sales management at companies including Johnson & Johnson and Intercept Pharmaceuticals, achieving significant revenue milestones and awards throughout his career.
Work at Nevro
John Logeman serves as the US Director of Market Development at Nevro since 2021. In this role, he has national responsibility and operates remotely from Dallas, Texas. He has been instrumental in driving growth and expansion initiatives within the organization. Logeman successfully delivered $48 million in revenue in the first full year following the launch of HFX for PDN. He also grew trial procedures volume significantly, increasing from 71 in Q4 2021 to 239 in Q2 2023.
Previous Experience at Johnson & Johnson
Prior to his current role, Logeman held multiple positions at Johnson & Johnson. He worked as the National Sales Director at LifeScan from 2016 to 2019, where he had national responsibility and was based in Dallas, Texas. He also served as the Senior District Manager at Janssen from 2013 to 2016, managing sales in the Southeast US. Additionally, he was a Senior Manager in Next Generation Development at LifeScan for eight months in 2012 to 2013.
Experience at Intercept Pharmaceuticals
Logeman was the Regional Business Director at Intercept Pharmaceuticals from 2019 to 2021. In this role, he managed responsibilities across the Southern US while based in Dallas, Texas. His experience in this position contributed to his extensive background in sales management and market development within the healthcare sector.
Education and Expertise
Logeman earned a Bachelor of Business Administration (BBA) in Marketing from The University of Texas at Austin, where he studied from 1994 to 1998. His educational background supports his expertise in sales management and market development across various sectors, including medical devices and pharmaceuticals.
Achievements in Sales Performance
Logeman has received recognition for his sales performance, including the 100% Club Award for delivering 108% to quota in 2022. He achieved the #1 region status in 2021 for the launch of HFX for PDN, demonstrating his ability to create an intentional culture and execute effective sales strategies. He also designed and implemented several training programs to support national growth and development needs.